抗氧化治疗对高血压患者抗氧化能力的影响

Ajay Mahaputra Kumar, Bhavesh Sadariya, Unmesh S Dave
{"title":"抗氧化治疗对高血压患者抗氧化能力的影响","authors":"Ajay Mahaputra Kumar, Bhavesh Sadariya, Unmesh S Dave","doi":"10.5455/njppp.2023.13.11526202219112022","DOIUrl":null,"url":null,"abstract":"Background: Hypertension is consistently related to the development of ischemic heart disease, heart failure, stroke, and chronic kidney disease. Oxidative stress has been associated with mechanisms of hypertension which could be nullified by antioxidants such as Vitamin C and Vitamin E. Aim and Objectives: The objectives of the study are as follows: (i) To estimate the impact of antioxidant therapy on antioxidant capacity in hypertensive patients; (ii) to measure serum levels of glutathione, glutathione peroxidase (GPx), glutathione reductase (GR), and superoxide dismutase (SOD) in hypertensive patients before and after giving them antioxidant therapy for 45 days. Materials and Methods: Thirty randomly selected hypertensive patients were given Supradyn tablet once a day for 45 days. Ferric reducing ability of plasma (FRAP), SOD, GR, GPx, and reduced Glutathione assays were measured before and after the intervention therapy. Results: Total antioxidant capacity as measured by serum FRAP in hypertensive patients before and after the therapy was increased significantly from 578.8 ± 60.85 to 592.1 ± 59.66 (μmol/L), respectively. The levels of SOD, GPx, GR, and Glutathione in hypertensive patients before giving antioxidant therapy were 1.6 ± 0.49 U/ml, 184.6 ± 17.1 μmol/L/min, 8.96 ± 1.15 μmol/L/min, and 8.03 ± 0.96 μmol/g of Hb, respectively. The same after giving them antioxidant therapy were 1.7 ± 0.46 U/ml, 182.4 ± 15.98 μmol/L/min, 8.83 ± 1.11 μmol/L/min, and 7.83 ± 0.94 μmol/g of Hb, respectively. The levels of GPx, GR, and Glutathione were significantly decreased after giving antioxidant therapy for 45 days while SOD level did not change significantly. Conclusion: Antioxidant therapies for 45 days led to a significant increase in total antioxidant capacity as shown by plasma FRAP levels and a significant decrease in serum levels of enzymatic antioxidants such as GPx, GR and Glutathione in hypertensive patients. However, serum levels of SOD did not show a significant change.","PeriodicalId":18969,"journal":{"name":"National Journal of Physiology, Pharmacy and Pharmacology","volume":"29 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of antioxidant therapy on antioxidant capacity in hypertensive patients\",\"authors\":\"Ajay Mahaputra Kumar, Bhavesh Sadariya, Unmesh S Dave\",\"doi\":\"10.5455/njppp.2023.13.11526202219112022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Hypertension is consistently related to the development of ischemic heart disease, heart failure, stroke, and chronic kidney disease. Oxidative stress has been associated with mechanisms of hypertension which could be nullified by antioxidants such as Vitamin C and Vitamin E. Aim and Objectives: The objectives of the study are as follows: (i) To estimate the impact of antioxidant therapy on antioxidant capacity in hypertensive patients; (ii) to measure serum levels of glutathione, glutathione peroxidase (GPx), glutathione reductase (GR), and superoxide dismutase (SOD) in hypertensive patients before and after giving them antioxidant therapy for 45 days. Materials and Methods: Thirty randomly selected hypertensive patients were given Supradyn tablet once a day for 45 days. Ferric reducing ability of plasma (FRAP), SOD, GR, GPx, and reduced Glutathione assays were measured before and after the intervention therapy. Results: Total antioxidant capacity as measured by serum FRAP in hypertensive patients before and after the therapy was increased significantly from 578.8 ± 60.85 to 592.1 ± 59.66 (μmol/L), respectively. The levels of SOD, GPx, GR, and Glutathione in hypertensive patients before giving antioxidant therapy were 1.6 ± 0.49 U/ml, 184.6 ± 17.1 μmol/L/min, 8.96 ± 1.15 μmol/L/min, and 8.03 ± 0.96 μmol/g of Hb, respectively. The same after giving them antioxidant therapy were 1.7 ± 0.46 U/ml, 182.4 ± 15.98 μmol/L/min, 8.83 ± 1.11 μmol/L/min, and 7.83 ± 0.94 μmol/g of Hb, respectively. The levels of GPx, GR, and Glutathione were significantly decreased after giving antioxidant therapy for 45 days while SOD level did not change significantly. Conclusion: Antioxidant therapies for 45 days led to a significant increase in total antioxidant capacity as shown by plasma FRAP levels and a significant decrease in serum levels of enzymatic antioxidants such as GPx, GR and Glutathione in hypertensive patients. However, serum levels of SOD did not show a significant change.\",\"PeriodicalId\":18969,\"journal\":{\"name\":\"National Journal of Physiology, Pharmacy and Pharmacology\",\"volume\":\"29 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"National Journal of Physiology, Pharmacy and Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5455/njppp.2023.13.11526202219112022\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"National Journal of Physiology, Pharmacy and Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/njppp.2023.13.11526202219112022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:高血压一直与缺血性心脏病、心力衰竭、中风和慢性肾脏疾病的发生有关。氧化应激与高血压的机制有关,而抗氧化剂如维生素C和维生素e可以消除氧化应激。目的和目的:本研究的目的如下:(1)估计抗氧化治疗对高血压患者抗氧化能力的影响;(ii)测定高血压患者抗氧化治疗前后45天血清谷胱甘肽、谷胱甘肽过氧化物酶(GPx)、谷胱甘肽还原酶(GR)、超氧化物歧化酶(SOD)水平。材料与方法:随机选择30例高血压患者给予舒普拉平片,每日1次,连用45 d。测定干预前后血浆铁还原能力(FRAP)、SOD、GR、GPx、还原性谷胱甘肽测定。结果:高血压患者治疗前后血清FRAP测定的总抗氧化能力分别从578.8±60.85 (μmol/L)提高到592.1±59.66 (μmol/L)。高血压患者抗氧化治疗前血清SOD、GPx、GR和谷胱甘肽水平分别为1.6±0.49 μmol/ ml、184.6±17.1 μmol/L/min、8.96±1.15 μmol/L/min和8.03±0.96 μmol/g Hb。抗氧化治疗后Hb含量分别为1.7±0.46 U/ml、182.4±15.98 μmol/L/min、8.83±1.11 μmol/L/min和7.83±0.94 μmol/g。抗氧化治疗45 d后GPx、GR和谷胱甘肽水平显著降低,SOD水平无明显变化。结论:抗氧化治疗45 d后,高血压患者血浆FRAP水平显著升高,血清GPx、GR、谷胱甘肽等酶促抗氧化剂水平显著降低。血清SOD水平无明显变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact of antioxidant therapy on antioxidant capacity in hypertensive patients
Background: Hypertension is consistently related to the development of ischemic heart disease, heart failure, stroke, and chronic kidney disease. Oxidative stress has been associated with mechanisms of hypertension which could be nullified by antioxidants such as Vitamin C and Vitamin E. Aim and Objectives: The objectives of the study are as follows: (i) To estimate the impact of antioxidant therapy on antioxidant capacity in hypertensive patients; (ii) to measure serum levels of glutathione, glutathione peroxidase (GPx), glutathione reductase (GR), and superoxide dismutase (SOD) in hypertensive patients before and after giving them antioxidant therapy for 45 days. Materials and Methods: Thirty randomly selected hypertensive patients were given Supradyn tablet once a day for 45 days. Ferric reducing ability of plasma (FRAP), SOD, GR, GPx, and reduced Glutathione assays were measured before and after the intervention therapy. Results: Total antioxidant capacity as measured by serum FRAP in hypertensive patients before and after the therapy was increased significantly from 578.8 ± 60.85 to 592.1 ± 59.66 (μmol/L), respectively. The levels of SOD, GPx, GR, and Glutathione in hypertensive patients before giving antioxidant therapy were 1.6 ± 0.49 U/ml, 184.6 ± 17.1 μmol/L/min, 8.96 ± 1.15 μmol/L/min, and 8.03 ± 0.96 μmol/g of Hb, respectively. The same after giving them antioxidant therapy were 1.7 ± 0.46 U/ml, 182.4 ± 15.98 μmol/L/min, 8.83 ± 1.11 μmol/L/min, and 7.83 ± 0.94 μmol/g of Hb, respectively. The levels of GPx, GR, and Glutathione were significantly decreased after giving antioxidant therapy for 45 days while SOD level did not change significantly. Conclusion: Antioxidant therapies for 45 days led to a significant increase in total antioxidant capacity as shown by plasma FRAP levels and a significant decrease in serum levels of enzymatic antioxidants such as GPx, GR and Glutathione in hypertensive patients. However, serum levels of SOD did not show a significant change.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信